3.0.0 2897 2025-12-05T21:17:31Z 2025-12-05T21:17:31Z Senate S S 2023-09-21 118 https://www.congress.gov/bill/118th-congress/senate-bill/2897 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred To 2023-09-21T18:34:47Z 118 3433 HR 2024-09-24 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Identical bill CRS 2023-09-21 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. IntroReferral 2023-09-21 Introduced in Senate IntroReferral 10000 9 Library of Congress B001267 Sen. Bennet, Michael F. [D-CO] Michael Bennet D CO N R000595 Sen. Rubio, Marco [R-FL] Marco Rubio R FL 2023-09-21 True S001181 Sen. Shaheen, Jeanne [D-NH] Jeanne Shaheen D NH 2023-10-31 False M000133 Sen. Markey, Edward J. [D-MA] Edward Markey D MA J. 2024-03-07 False K000367 Sen. Klobuchar, Amy [D-MN] Amy Klobuchar D MN 2024-03-21 False V000128 Sen. Van Hollen, Chris [D-MD] Chris Van Hollen D MD 2024-03-21 False B001310 Sen. Braun, Mike [R-IN] Mike Braun R IN 2024-09-12 False Health Health 2023-10-11T17:15:21Z

00 2023-09-21 Introduced in Senate 2024-01-09T18:31:58Z <p><b>Give Kids a Chance Act of 2023</b></p> <p>This bill authorizes certain targeted clinical trials involving combinations of drugs to treat pediatric cancer.</p> <p>Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations so as to authorize investigations of new drugs that are used in combination with active ingredients that have already been approved and that (1) have been determined to be the standard of care for treating a pediatric cancer, or (2) have been approved to treat an adult cancer and are directed at molecular targets for pediatric cancer.</p> <p>The Food and Drug Administration must issue guidance and report on the bill's implementation. The Government Accountability Office must report on the effectiveness of the bill's changes with respect to the development of pediatric cancer drugs.</p>

Display Title 45 2024-09-13T11:03:18Z Short Title(s) as Introduced 101 2024-05-24T13:36:18Z Introduced in Senate IS Official Title as Introduced 6 2024-03-08T09:08:21Z Introduced in Senate IS Introduced in Senate 2023-09-21T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s2897is/xml/BILLS-118s2897is.xml 2023-09-21 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.